FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

391792002: Atosiban (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2736839019 Atosiban (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2768723016 Atosiban en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
58081000195119 atosiban it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
792651000172119 atosiban fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
74221000195118 Atosiban de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atosiban (substance) Is a Drug, medicament or biological substance false Inferred relationship Some
Atosiban (substance) Is a Antihormone false Inferred relationship Some
Atosiban (substance) Is a Peptide hormone receptor antagonist true Inferred relationship Some
Atosiban (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Peptide hormone receptor antagonist (disposition) true Inferred relationship Some
Atosiban (substance) Is a Peptide true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing atosiban (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atosiban (substance) Inferred relationship Some 1
atosiban 7,5 mg/mL, fiole de 0,9 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atosiban (substance) Inferred relationship Some
atosiban 7,5 mg/mL, fiole de 5 mL de concentré pour perfusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atosiban (substance) Inferred relationship Some
Atosiban acetate (substance) Is a False Atosiban (substance) Inferred relationship Some
Product containing precisely atosiban (as atosiban acetate) 37.5 milligram/5 milliliter conventional release solution for infusion vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Atosiban (substance) Inferred relationship Some 1
Product containing precisely atosiban (as atosiban acetate) 6.75 milligram/0.9 milliliter conventional release solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Atosiban (substance) Inferred relationship Some 1
Atosiban acetate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Atosiban (substance) Inferred relationship Some
Atosiban-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atosiban (substance) Inferred relationship Some 1
Atosiban only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atosiban (substance) Inferred relationship Some 1
Product containing only atosiban in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atosiban (substance) Inferred relationship Some 1
Atosiban (as atosiban acetate) 7.5 mg/mL solution for infusion This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Atosiban (substance) Inferred relationship Some 1
Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Atosiban (substance) Inferred relationship Some 1
Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Atosiban (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start